No popular authors found.
Ads by Google:

Categories

No categories found.


Get Celiac.com's E-Newsletter





Ads by Google:


Follow / Share


  FOLLOW US:
Twitter Facebook Google Plus Pinterest RSS Podcast Email  Get Email Alerts
SHARE:

Popular Articles

No popular articles found.
Celiac.com Sponsors:

T-cell-mediated Immune Regulation in the GI Tract

A team of Swiss researchers recently set out to examine the nature of T cell-mediated immuno-regulation in the gastrointestinal tract. The research team was made up of doctors L. Saurer and C. Mueller of the Institute of Pathology at the University of Bern in Switzerland.

In the human intestinal tract, just a single layer of epithelial cells divides innate and adaptive immune effector cells from a wide array of antigens. Here, the immune system faces a tall task in accepting beneficial flora and dietary antigens while preventing the dissemination of potential pathogens. When the tightly controlled process of immune system reactions breaks down, harmful inflammation and damage may result.

In light of this, a great deal of focus has shifted toward 'conventional' regulatory CD4+ T cells, including naturally occurring and adaptive CD4+ CD25+ Foxp3+ T cells, Th3 and Tr1 cells.

Ads by Google:

However, control mechanisms in the intestinal mucosa are highly intricate, and include adaptations of non-haematopoietic cells and innate immune cells in addition to the presence of unconventional T cells with regulatory properties such as resident TCRγδ or TCRαβ CD8+ intraepithelial lymphocytes.

In the study, L. Saurer and C. Mueller seek to provide an overview of the present body of knowledge on standard and non-standard regulatory T cell subsets (Tregs), with particular focus on clinical data and the potential role or malfunctioning of Tregs in four major human gastrointestinal diseases, i.e. inflammatory bowel diseases, celiac disease, food allergy and colorectal cancer.

Their data confirms most of the findings derived from experimental animal models, and has implications for clinical immunology, food allergy, immunoregulation, immunotherapy, mucosal immunology, and regulatory T cell protocols. Their findings appear in the February 2009 issue of Allergy.


Celiac.com welcomes your comments below (registration is NOT required).












Related Articles



Comments




Rate this article and leave a comment:
Rating: * Poor Excellent
Your Name *: Email (private) *:




In Celiac.com's Forum Now:


Welcome! Here is a link to our Newbie 101 thread that you might find useful. I can only comment on those foods that I have in my home or have purchased. 1. Nutella is and it states it in the label. 2. Skippy PB is gluten-free (not stated, but ingrediants are). 3. ...

In the beginning, you might find ANY gluten free bread abhorrent. So, you might wait a few months to give yourself time to forget what wheat bread tasted like.

In my brief research, I did not find any public papers indicating villi blunting for Losartan specifically. There was research and a law suit on olmesartan (other celiac.com members have pointed out). Dr. Hart may have been making clinical observations or has access to medical research that is...

I did find a local store that carries the Canyon House brand and will give that a try. It can be tough as I live in a fairly rural area and we don't have a lot of the resources many of the more urban areas do. It is a 1 hour round trip just to get to the closest town with anything like a Trader ...

Hello, Often drugs that end in ?artan are ARBs, and they work by blocking the angiotensin receptors. I?m not sure what the exact difference is between the two medications you mention, though. Have you called the manufacturer of losartan to see if any of the fillers contain gluten? It might b...